Medicis Pharmaceutical Corp. (MRX) Tops Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $64.72 -1.72%
EPS Growth %: +22.5%
Financial Fact:
Net product revenues: 179.13M
Today's EPS Names:
FCNCA, PBCO, ARBV, More
EPS Growth %: +22.5%
Financial Fact:
Net product revenues: 179.13M
Today's EPS Names:
FCNCA, PBCO, ARBV, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q1 EPS of $1.48, $0.10 better than the analyst estimate of $1.38. Revenue for the quarter came in at $692.3 million versus the consensus estimate of $686.37 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA Committee Recommends To Widen Access To Bpc-157 Peptide
- Rollins shares plunge premarket after Q2 miss triggers downgrades
- AMD Announces Helios AI Server Computer Rack
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
